Suffering from Serious Ozempic, Wegovy, or Rybelsus Side Effects?
Take Action Now

Semaglutides and other GLP-1 drugs like Ozempic have exploded in popularity, but they can cause severe medical problems that affect the gastrointestinal tract, including:

  • Severe and prolonged vomiting

  • Stomach paralysis (gastroparesis)

  • Intestinal paralysis (ileus)

  • Bowel or intestinal obstruction

If you experienced serious health issues after taking Ozempic, Wegovy, Rybelsus, Mounjaro, or any weight loss drugs, you may be eligible for compensation. The attorneys of Bursor & Fisher, P.A. can help you take legal action.

Get Your Free Case Review Today

First Name
Last Name
Phone Number
Email Address
Additional Info
Satisfied Clients

Weight Loss Medications Linked to Severe Gastrointestinal Issues

Ozempic has been hailed as a breakthrough for weight loss and diabetes management. An estimated 1 in 8 Americans have taken GLP-1 drugs. But behind the success lies a disturbing reality. Patients are coming forward with claims of severe gastrointestinal complications, including stomach paralysis and life-threatening intestinal obstructions. Lawsuits filed nationwide accuse weight loss drug manufacturers Novo Nordisk and Eli Lilly and Company of failing to warn consumers about these risks, causing many patients to suffer in silence.

Legal Compensation May Be Available for Ozempic Patients

As reports of excruciating pain, uncontrollable vomiting, and emergency surgeries mount, the attorneys of Bursor & Fisher, P.A. are here to help. Ozempic, Wegovy, Rybelsus, and Mounjaro patients can turn to us to file their own legal claims for GLP-1 drug injuries. Our team of lawyers can help you explore your legal options during a free, no-obligation case evaluation. Any financial remedies you receive can address your devastating health complications, steep medical bills, lost wages, and long-term changes to your overall quality of life.

Proven Case Results from a Trusted Law Firm

The attorneys at Bursor & Fisher, P.A., are dedicated to securing the highest verdicts and settlements for our clients. We have represented more than 160 million people in legal actions—that’s roughly 1 in every 2 Americans. Our goal is to ensure you receive fair compensation that realistically accounts for and addresses your pain, suffering, and hardships.
Jury Verdict of $267M Against debt collector that  made millions on illegal robocalls.
Trial Victory of $299M For class of 1.9 million Sprint customers who were charged illegal fees.
We represented 3,000+ Military veterans and family of military veterans injured or killed by exposure to toxic water at Camp Lejeune.

Experienced Lawyers Ready to Help Ozempic Patients

Scott A. Bursor President
Scott A. Bursor is the President of Bursor & Fisher, P.A. He focuses his practice on complex civil litigation and class actions. Class actions rarely go to trial. Scott tried 6 class action cases to juries, and won all 6, achieving awards ranging from $21 million to $299 million. Scott’s most recent trial victory came in May 2019 in Perez v. Rash Curtis & Associates, in federal court in Oakland, California, where he won a $267 million jury verdict against a debt collector for violations of the Telephone Consumer Protection Act (TCPA).
Sarah N. Westcot Managing Partner
Sarah N. Westcot is the Managing Partner of Bursor & Fisher’s Miami office. Sarah is an experienced litigator who has devoted her practice to seeking justice for clients who have been injured and wronged. Sarah has been chosen by judges to serve on Plaintiff Steering Committees and Plaintiff Executive Committees in national litigations included In re Oral Phenylephrine Marketing and Sales Practices Litigation (MDL No. 3089), In re Zantac (Ranitidine) Products Liability Litigation (MDL No. 2924), In re Apple Inc. App Store Simulated Casino-Style Games Litigation (MDL No 2985), and In Re: Google Play Store Simulated Casino-Style Games Litigation (MDL No. 3001).